Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. (Q45906744)

17 December 2017

title

Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. (English)

1 reference

17 December 2017

author name string

J M R Lambert

1

1 reference

17 December 2017

A Moshfegh

2

1 reference

17 December 2017

P Hainaut

3

1 reference

17 December 2017

K G Wiman

4

1 reference

17 December 2017

V J N Bykov

5

1 reference

17 December 2017

language of work or name

English

0 references

publication date

30 November 2009

1 reference

17 December 2017

published in

Oncogene

1 reference

17 December 2017

volume

29

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

1329-1338

1 reference

17 December 2017

Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Repression of new p53 targets revealed by ChIP on chip experiments.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Cytoplasmic functions of the tumour suppressor p53.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Mdm2 promotes the rapid degradation of p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Endoplasmic reticulum stress induced by oxidative stress in retinal pigment epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

The p53MH algorithm and its application in detecting p53-responsive genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Developmentally regulated expression of calponin isoforms and the effect of h2-calponin on cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Thapsigargin, a high affinity and global inhibitor of intracellular Ca2+ transport ATPases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Reactive oxygen species are downstream mediators of p53-dependent apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Regulation of p53 stability by Mdm2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

PRIMA-1 reactivates mutant p53 by covalent binding to the core domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Keeping mammalian mutation load in check: regulation of the activity of error-prone DNA polymerases by p53 and p21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

The IARC TP53 database: new online mutation analysis and recommendations to users

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

A model for p53-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

hTERT antagonizes p53-induced apoptosis independently of telomerase activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

PRIMA-1(MET) induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

The antioxidant function of the p53 tumor suppressor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Live or let die: the cell's response to p53

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.425

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.425

1 reference

17 December 2017

Dimensions Publication ID

1006160201

0 references

1 reference

17 December 2017